EUROTOX 2026

InSphero is attending EUROTOX 2026

Join us at EUROTOX 2026 in Vienna, Austria, where the global toxicology community will come together to exchange scientific advances, explore emerging approaches, and shape the future of safety assessment.

We’re looking forward to connecting with researchers across the field and sharing how human-relevant 3D in vitro models can provide deeper, organ-specific insights into drug safety. Our toxicology platforms span liver, gastrointestinal, neuro, and pancreatic models, supporting more physiologically relevant approaches to investigating toxicity and generating meaningful data earlier in development.

By combining advanced 3D biology with scalable, reproducible workflows, these models are designed to help researchers better understand organ-specific responses and translate complex biology into actionable safety insights.

Explore all our activities taking place during EUROTOX 2026 from Sunday, September 13th to Wednesday, September 16th in Vienna. See you there!

 

Meet our Team at EUROTOX 2026

Bruno Filippi

Bruno Filippi, PhD

Vice President, Liver Safety

Aline Roch, PhD

Head or R&D at DOPPL, now part of InSphero
Wolfgang

Wolfgang Moritz, PhD

Head of External Collaborations, Co-founder

Bärbel Ulmer, PhD

Director of Business Development

Our Booth at EUROTOX 2026

Visit our booth #8 and discover our physiological, reproducible, and scalable 3D in vitro safety models designed to support more  predictive insights for drug development.

 

Posters at EUROTOX 2026

Enabling Early Safety Assessment with Low-Input RNA-Seq in Liver Microtissues Across Species and Compound Analogs

Date: Tuesday, September 15, 2026 | 9:30 am

Poster Number: P30-32

Abstract Number: 1330

Bruno Filippi

Bruno Filippi, PhD

Vice President, Liver Safety

MASLD increases sensitivity to chlorpromazine- and trovafloxacin-induced toxicity in a 3D InSight™ human liver spheroid model

Date: Monday, September 14, 2026 | 9:30 am

Poster Number: P19-01

Abstract Number: 991

Bärbel Ulmer, PhD

Director of Business Development

Drug-induced gastrointestinal toxicity assessment – the human small intestinal organoid assay for drug testing

Date: Monday, September 14, 2026 | 9:30 am

Poster Number: P16-06

Abstract Number: 1298

Visit the Tecan booth #16 to see high throughput organoid imaging in the Gri3D® plate!

Aline Roch, PhD

Head or R&D at DOPPL, now part of InSphero

Toward patient-relevant DILI testing: Integrating intrinsic liver vulnerability with systemic metabolic cues

Date: Monday, September 14, 2026 | 9:30 am

Poster Number: P19-02

Abstract Number: 1004

Wolfgang

Wolfgang Moritz, PhD

Head of External Collaborations, Co-founder

Collaborative Posters at EUROTOX 2026

An integrative in silico framework for derisking drug-induced liver injury (DILI) liabilities

Authors: D. Lopez Rodriguez, J. Overman, C. Adessi, M. Correa Marrero, M. Marchesi, R. Matheis, F. Boess, B. G.H. Filippi, B. Ulmer, S. Hauri, J. Keemink, K. Umehara, S. Kustermann, T. Y. Doktorova

Date: Monday, September 14, 2026 | 9:30 am

Poster Number: P18-24

Abstract Number: 858

EUROTOX 2026 Resources

Safety and Efficacy of HexaBody-DR5/DR5 in MalignantSolid Tumors: Phase 1/2a Results and Translational InsightsInto Observed Hepatotoxicity
Complex in vitro model developers’ perspective on advanced hepatic in vitro culture methods for predictive drug safety
Non-Destructive Multiplexed Imaging of 3D Liver Microtissues for Multi-Modal DILI Assessment
High-throughput single organoid swelling assay for personalized evaluation of CFTR modulators in patient-derived rectal organoids
Influence of 3-dimensional architecture and coculture on in vitro CYP enzyme metabolism and induction: Benchmarking human hepatic spheroids for studies in drug development
A Long‐Term Human Liver Spheroid Model for Assessing Silencing and Durability of GalNAc‐Conjugated siRNAs
Utilizing Cross-species In Vitro Models to Proactively Flag DILI Mechanisms Missed by Traditional Preclinical Testing
3D InSight™ Drug-Induced Gastrointestinal Toxicity Assessment – The human small intestinal organoid assay for drug testing
Scroll to Top

Your Success is Our Mission - Get in Touch

Fill in form below to contact our 3D in vitro experts

Sign up for our Newsletter

Get the latest news on 3D in vitro research

Webinar registration

Fill in the form below to register

View resource

Fill in the form below to view this resource